MIR4521 Gene

HGNC Family Non-coding RNAs
Name microRNA 4521
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐4521 has emerged as a significant regulator in several malignancies. In one study on gastric carcinoma, an array of candidate microRNAs was identified with potential relevance to metastasis, prompting further exploration of their modulatory roles in tumor progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In esophageal cancer, miR‐4521 was incorporated into a prognostic risk model, with its altered expression correlating with tumor aggressiveness, immune infiltration, and other microenvironment features."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Moreover, functional experiments in medulloblastoma demonstrated that loss of miR‐4521 leads to upregulation of the oncogenic transcription factor FOXM1 and its downstream effectors, thereby promoting cell proliferation, invasion, and aberrant cell cycle progression—findings that underscore its tumor‐suppressive role."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Broader studies in hepatocellular carcinoma further reinforce the significance of microRNAs in oncogenesis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", while investigations in breast cancer have revealed that sequences of miR‐4521 are embedded within tRNA‐derived fragments (tRFs), suggesting a dual biomarker potential that warrants additional study."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n \nIn the context of neurological disorders, notably in patients with refractory epilepsy associated with focal cortical dysplasia, hsa‐miR‐4521 was found to be markedly up‐regulated in both brain tissue and serum. This significant elevation positions miR‐4521 as a promising diagnostic biomarker for early identification of such epileptogenic pathologies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n \nIn studies addressing cardiovascular complications related to type 2 diabetes, dysregulated MIR4521 expression has been implicated in vascular endothelial dysfunction. Mechanistic insights revealed that the circular RNA circHMGCS1 acts as a sponge for MIR4521, leading to overexpression of arginase 1, reduced nitric oxide secretion, enhanced production of reactive oxygen species, and increased expression of adhesion molecules—factors that collectively impair vasodilation and exacerbate endothelial injury. These findings highlight the potential therapeutic value of modulating MIR4521 to attenuate diabetes‐associated vascular damage."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Shan Xing, Zhi Tian, Wenying Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-020-01295-2"}], "href": "https://doi.org/10.1186/s12943-020-01295-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33407516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33407516"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yue Zhao, Li Xu, Xinyu Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel prognostic mRNA/miRNA signature for esophageal cancer and its immune landscape in cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.12902"}], "href": "https://doi.org/10.1002/1878-0261.12902"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33463006"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33463006"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Daniel Senfter, Mahzeiar Samadaei, Robert M Mader, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High impact of miRNA-4521 on FOXM1 expression in medulloblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-1926-1"}], "href": "https://doi.org/10.1038/s41419-019-1926-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31541075"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31541075"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Munawar Ayesha, Abbasi Majid, Dongting Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Adv Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jare.2021.05.003"}], "href": "https://doi.org/10.1016/j.jare.2021.05.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35127170"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35127170"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Shaharbhanu A Hussain, Kunhi Valappil Deepak, Dechamma Pandyanda Nanjappa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparative expression analysis of tRF-3001a and tRF-1003 with corresponding miRNAs (miR-1260a and miR-4521) and their network analysis with breast cancer biomarkers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-021-06732-z"}], "href": "https://doi.org/10.1007/s11033-021-06732-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34661810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34661810"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xiaofeng Wang, Yuqiang Sun, Zeshi Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum MicroRNA-4521 is a Potential Biomarker for Focal Cortical Dysplasia with Refractory Epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurochem Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11064-015-1773-0"}], "href": "https://doi.org/10.1007/s11064-015-1773-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26645999"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26645999"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ming Zhang, Guangyi Du, Lianghua Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "HMGCS1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " sponges "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MIR4521"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " to aggravate type 2 diabetes-induced vascular endothelial dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.97267"}], "href": "https://doi.org/10.7554/eLife.97267"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39235443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39235443"}]}]}]}
Synonyms MIR-4521
NCBI Gene ID 100616406
API
Download Associations
Predicted Functions View MIR4521's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR4521's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR4521's ARCHS4 Predicted Functions.

Functional Associations

MIR4521 has 1,245 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 8 datasets.

Click the + buttons to view associations for MIR4521 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4521 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4521 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR4521 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR4521 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR4521 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4521 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR4521 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR4521 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.